2015 China (Chongqing) biomedical frontier technology and industrialization development seminar

With the implementation of "healthy China 2020", "made in China 2025" and other national plans, as well as the continuous deepening of the reform of national medical reform, drug and medical device review and approval system and the vigorous promotion of a series of measures, it will become "13th five year plan" and "no plan" to encourage biomedical innovation, improve product quality, strengthen international cooperation, promote the transformation of scientific and technological achievements and industrial transformation and development The main theme of the development of biomedical industry in China In order to actively promote the frontier technology innovation and cooperation and exchange of biomedicine, and promote the collaborative innovation and industrial cluster development of Chongqing biomedicine, China Pharmaceutical Enterprise Development Promotion Association and China pharmaceutical scientific and technological achievements transformation center jointly hold the "2015 China (Chongqing) frontier technology and industrialization development seminar" jointly with Chongqing pharmaceutical Industry Development Office in December 2015 The conference will invite famous domestic transformation institutions and authoritative experts of industrialization to give excellent reports on industrial innovation, scientific research innovation, transformation innovation, innovation construction of industrialization platform, industrial clustering construction and collaborative innovation of scientific research industry Conference name: 2015 China (Chongqing) biomedical cutting edge technology and industrialization development conference time: December 19, 20, 2015, report to the conference venue: Chongqing Yuzhou Hotel (state guesthouse) China hall, No 168, Yuzhou Road, Yuzhong District, Chongqing sign up for the seminar on activists! Quick registration address: http://www.houdongjia.com/event-1802826.html organization Sponsor: China Association for the promotion of pharmaceutical enterprise development, China Center for the transformation of pharmaceutical scientific and technological achievements guidance unit: Chongqing pharmaceutical industry office co organizer: Chongqing pharmaceutical industry association organizer: Journal of the Third Military Medical University, Gao Sheng pharmaceutical, Weston biological participants and scale The scale of this conference will reach 300-400 people, mainly for representatives of biomedical enterprises, scientific research institutes, R & D institutions, clinical research, investment institutions, innovation services and other relevant units Agenda of the meeting part I of the morning of December 19 theme: opening ceremony and leaders' speech, and "13th five year plan" China's biomedical industry development related policy trend presided over by guests: Zhang natural, vice president of China over the counter drug association 09:30-09:40 welcome speech by the founder of high earning foreign exchange 09:40-09:50 speech by the leaders of Chongqing Science and Technology Commission 09:50-10:00 speech by the leaders of Chongqing Economic and Information Technology Commission 10: 00-10:40 theme report: "13th five year plan" China's biomedical industry development related policy trends (to be invited: Science and technology development center of the health and Family Planning Commission, Drug Administration Department of the health and Family Planning Commission, biotechnology development center of the Ministry of science and technology, consumer goods department of the Ministry of industry and information technology, high technology department of the national development and Reform Commission) 10:40-11:00 brilliant report by Wei Yu 11: 00-11:20 theme report: development trend and model innovation of international cooperation in pharmaceutical innovation 11:20-11:30 excellent report by Zhang Yilong, President of Chongqing pharmaceutical industry association 11:30-11:50 preferential policies and prospects for pharmaceutical development in Chongqing (Chongqing pharmaceutical industry development office) 11:50-12:00 concept of whole industry chain transformation platform for biomedical industry (representative of high foreign exchange earning) 12:00-12:10 group photo of guests on the afternoon of December 19 Part II theme: Seminar on pharmaceutical innovation and industrialization development presided over by: Liu Xuejun, President of Pharmaceutical Industry Research Institute of Shanghai Fosun Pharmaceutical Group 13:30-13:50, director of innovative drug research and development center of Chongqing University, Thousand Talents Program (to be invited) topic: (tentative) 13:50-14:10 director of Biochemistry and cell biology research Institute of Shanghai Institute of life sciences, Chen Ming Chinese Academy of Sciences Title: innovation driven new drug screening and R & D platform construction 14:10-14:30 Zou Quanming, director of Chongqing biopharmaceutical Engineering Technology Research Center Title: industrialization development and Prospect of innovative drugs 14:30-14:50 Yang Dajian, President of Chongqing Institute of traditional Chinese medicine Title: scientific and technological achievements equity activating intangible assets 14:50-15:00 tea break 15: 00-15:20 Li Shugang, general manager of Chongqing Kerun biomedical research and Development Co., Ltd Title: innovative development and industrialization of protein medicine Title: current situation, problems and Countermeasures of research and development of innovative drugs for cardiovascular and cerebrovascular diseases (tentative) 16:00-16:20 Liu Xuejun president of Pharmaceutical Industry Research Institute of Shanghai Fosun Pharmaceutical Group Title: (tentative) 16:20-16:40 general manager of step swimming meter intranet Title: China's three major terminals, six major market development reports and 2016 forecast 16:40-17:00 guests answer questions and interact (only five questions) On the morning of December 20, the third part of the theme: Discussion on the transformation of frontier technologies in biomedicine presided over by the guest: Director of Editorial Department of Journal of the Third Military Medical University of Leng huaiming 09:00-09:20 Dong Xiaoyan president of Beijing Wujiahe Molecular Medicine Research Institute Co., Ltd Title: AAV (adeno-related virus) - innovative development and application of gene therapy (tentative) 09:20-09:40 general manager of wuxufeng Huada protein Center Title: innovative application of iTRAQ and SILAC in molecular diagnosis (tentative) 09:40-10:00 Xiao Yunping, general manager of Shanghai Ouyi Biomedical Technology Co., Ltd Title: analysis of research strategy of innovative drug mircrorna / lncrna (tentative) 10:20-10:00 Tang Xiaosheng, Chongqing University "hundred talents plan", expert title of nanomaterials technology: biological application of I-III-VI semiconductor quantum dot materials 10: 00-10:20 tea break 10:20-10:50 Cui Hongjuan silkworm genome of Southwest University, National Key Laboratory Title: epigenetic regulation of tumor and target design of cancer treatment 11: 10-11:30 Dr Pei Desheng, researcher, winner of "hundred talents plan" of Chinese Academy of Sciences, director of environment and health research center of Chongqing Institute of green and intelligent technology, Chinese Academy of Sciences Title: low cost rapid screening of circulating tumor cells based on microfluidic chip in the afternoon of December 20 host guest: Zhao Jing, vice president of Basic Medical School of Chongqing Medical University 13: 30-13:50 Wang Yanjiang, director of Department of Neurology, Daping Hospital, the Third Military Medical University, doctoral supervisor Title: Alzheimer's disease prevention and control target and strategy 13:50-14:10 Beijing Nuohe source Title: technology transformation and application of single cell sequencing (tentative) 14:10-14:30 Li Gang, Professor of Chongqing University, doctoral supervisor Title: low cost and rapid screening of circulating tumor cells based on microfluidic chip Professor Fu ailing, Fudan University, School of pharmacy, postdoctoral Southwest University Title: polypeptide guided selective entry of exogenous substances into nerve cells 14:50-15:10 tea break 15:10-15:30 homeostasis Title: application of intellectual property rights in pharmaceutical transformation 15:30-15:50 shen you Feng, CRISPR/Cas9 technical director of the title: CRISPR/Cas9 technology innovation, 15:50-16:10, Li Tianquan pharmaceutical and wisdom network co founder, R & D Manager, senior engineer: through data perspective, China's new drug research and development situation and trend are more relevant to the conference information Please pay attention to the official WeChat official account: VESERVICE For more high-quality conference content and dry goods, please download the activist app